Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.947 | 95 | 78 | 1991 | 2019 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.610 | None | 1.000 | 3 | 3 | 2009 | 2012 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.500 | None | 0.981 | 53 | 8 | 1988 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
group | 0.500 | None | 1.000 | 46 | 3 | 2008 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.500 | None | 1.000 | 29 | 4 | 2010 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.500 | None | 1.000 | 19 | 5 | 1999 | 2017 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.480 | None | 0.889 | 9 | 2 | 2002 | 2017 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.400 | None | 0.931 | 29 | 1 | 1994 | 2019 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
group | 0.400 | None | 1.000 | 26 | 0 | 1992 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.400 | None | 0.938 | 16 | 1 | 1994 | 2017 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.350 | None | 1.000 | 7 | 1 | 1996 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
group | 0.350 | None | 0.833 | 6 | 0 | 1996 | 2019 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
group | 0.350 | None | 1.000 | 6 | 0 | 2010 | 2017 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
group | 0.340 | None | 1.000 | 5 | 0 | 1984 | 2012 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
group | 0.340 | None | 1.000 | 5 | 0 | 1995 | 2008 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.330 | None | 1.000 | 4 | 3 | 2001 | 2017 | ||||||||
|
Yes associated protein 1 | 0.432 | 0.808 | 1.00 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2011 | 2017 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
group | 0.320 | None | 1.000 | 3 | 2 | 2005 | 2010 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2012 | 2018 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2003 | 2011 | ||||||||
|
patched 1 | 0.398 | 0.885 | 1.00 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 1998 | 1998 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2004 | 2011 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2008 | 2011 | ||||||||
|
transglutaminase 2 | 0.445 | 0.808 | 6.8E-18 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2005 | 2011 |